|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:822-829
© 2005 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Division of Cardiology, Children's Memorial Hospital, The Feinberg School of Medicine at Northwestern University, Chicago, Ill
b Division of Critical Care Medicine, Children's Memorial Hospital, The Feinberg School of Medicine at Northwestern University, Chicago, Ill
c Division of Cardiovascular Thoracic Surgery, Children's Memorial Hospital, The Feinberg School of Medicine at Northwestern University, Chicago, Ill
d Division of Critical Care Medicine and Cardiology, St Louis Children's Hospital, Washington University School of Medicine, St Louis, Mo.
Received for publication January 7, 2005; revisions received February 28, 2005; accepted for publication March 8, 2005. * Address for reprints: John M. Costello, MD, Cardiac ICU Office, Children's Hospital Boston, 300 Longwood Ave, FA 105, Boston, MA 02115-5724. (Email: john.costello{at}cardio.chboston.org).
OBJECTIVES: We sought to determine the effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children and to assess whether such changes are associated with morbidity.
METHODS: At 6 perioperative time points in 25 patients, plasma levels of atrial natriuretic peptide, brain natriuretic peptide, and guanosine 3', 5'-monophosphate were measured, and the biologic activity of the natriuretic hormone system was quantified. Relationships were sought between changes in brain natriuretic peptide levels, biologic activity, and a number of morbidity indicators.
RESULTS: There was a significant change in atrial natriuretic peptide levels (P = .037), brain natriuretic peptide levels (P = .001), and biologic activity of the natriuretic hormone system (P = .009) over the first 4 time points in the study. Atrial natriuretic peptide levels transiently decreased from baseline to 12 hours after surgical intervention. Compared with baseline values, brain natriuretic peptide levels were increased at 12 hours after surgical intervention and on postoperative day 1. The increase in brain natriuretic peptide levels from baseline to 12 hours after surgical intervention was associated with cardiopulmonary bypass time (r s = 0.4, P = .047). The biologic activity transiently decreased from baseline to intensive care unit admission but was not associated with any morbidity indicators.
CONCLUSIONS: Increased postoperative brain natriuretic peptide levels are associated with longer bypass times. The biologic activity of the natriuretic hormone system is transiently impaired. Larger studies should investigate brain natriuretic peptide as a predictor of postoperative morbidity and the potential for natriuretic hormone infusions to improve postoperative hemodynamics and urine output.
This article has been cited by other articles:
![]() |
K. Francois, T. Bove, K. De Groote, J. Panzer, K. Vandekerckhove, B. Suys, D. De Wolf, and G. Van Nooten Pleural effusions, water balance mediators and the influence of lisinopril after completion Fontan procedures Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 57 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Heeb, R. S. Baker, C. Lam, M. Basu, W. Lubbers, J. Y. Duffy, and P. Eghtesady Role of Natriuretic Peptides in cGMP Production in Fetal Cardiac Bypass. Ann. Thorac. Surg., March 1, 2009; 87(3): 841 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Hsu, P. E. Oishi, R. L. Keller, O. Chikovani, T. R. Karl, A. Azakie, I. Adatia, and J. R. Fineman Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 746 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Mainwaring, C. Parise, S. B. Wright, A. L. Juris, R. A. Achtel, and H. Fallah Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair Ann. Thorac. Surg., December 1, 2007; 84(6): 2066 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Hsu, R. L. Keller, O. Chikovani, H. Cheng, S. A. Hollander, T. R. Karl, A. Azakie, I. Adatia, P. Oishi, and J. R. Fineman B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 939 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cannesson, C. Bionda, B. Gostoli, O. Raisky, S. di Filippo, D. Bompard, C. Vedrinne, R. Rousson, J. Ninet, J. Neidecker, et al. Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation Anesth. Analg., May 1, 2007; 104(5): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |